HAE Treatment Guidelines
To help fill the gap in unmet needs for patients with hereditary angioedema (HAE), the International World Allergy Organization (WAO) and the European Academy of Allergy and Clinical Immunology (EAACI) have created consensus guidelines for the diagnosis and management of HAE.
When developing a treatment plan for your HAE patients, consider referring to the following evidence-based recommendations put forth by the WAO/EAACI.

Lexi
Real TAKHZYRO patient
Lexi
Real TAKHZYRO patient
WAO/EAACI Recommendations
for preventive treatment1
Preventive treatment, or long-term prophylaxis, refers to the use of regular medication to reduce the severity and frequency of HAE attacks. Preventive treatment should be individualized to meet the needs of each patient and take the following into consideration:
- Severity and frequency of attacks
- Past laryngeal attacks
- Availability of healthcare resources
- Patient’s personal preference
Since these factors can change over time, all patients with HAE should be evaluated for preventive treatment at every visit, at least once a year.
WAO/EAACI Recommendations for acute treatment1
Because HAE attacks can still occur despite the use of preventive treatment, all patients should have access to on-demand, or acute, treatment. Remind patients to always have acute treatment on hand.
Partner with your patients
It’s important to create an individualized treatment plan in close partnership with your patients that includes an emergency plan.1 Working closely with patients will also help ensure that their treatment plan continues to evolve as needed.